Month: June 2020

Brooklyn, NY, June 02, 2020 (GLOBE NEWSWIRE) —  – Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading multi-industry technology company that is driving innovation in a wide range of commercial sectors such as Internet of Things (IoT), Augmented and Virtual Reality (AR & VR), and Artificial Intelligence and Computer Vision (AI & CV), today announced it has entered into definitive agreements with institutional investors for the purchase and sale of 3,055,556 shares of its common stock at a purchase price of $1.80 per share in a registered direct offering priced at-the-market under Nasdaq rules for gross proceeds of $5.5 million before deducting placement agent fees and expenses. The closing of the offering is expected to occur on or about June 4, 2020, subject to the satisfaction of customary closing conditions.Cemtrex...

OTTAWA, June 02, 2020 (GLOBE NEWSWIRE) — Teledyne Lumenera, a Teledyne Technologies [NYSE:TDY] company, and manufacturer and developer of digital cameras for industrial and scientific imaging applications, is pleased to announce the release of its new Lt Series USB3 cameras. With robust compact enclosures and fully-locking USB3 connectors, these new cameras are built for rugged 24/7 use. Equipped with the latest rolling shutter Starvis™ CMOS sensors and global shutter Pregius™ CMOS sensors from Sony®, and ranging in resolution from 2-20 megapixels, these new cameras perform in a wide variety of imaging applications such as aerial imaging, Intelligent Traffic Systems (ITS), robotic inspection solutions, and life sciences. Teledyne Lumenera’s Lt Series Cameras offer a smaller, lighter, and lower cost imaging solution and are designed...

加拿大渥太华, June 02, 2020 (GLOBE NEWSWIRE) — 工业和科学成像应用数码相机的制造商和开发商，Teledyne Technologies [NYSE:TDY] 公司旗下的 Teledyne Lumenera 很高兴宣布推出其最新的Lt 系列 USB3 相机。这些新型相机具有坚固的紧凑型外壳和完全锁定的 USB3 连接器，全天候耐用。该系列新型相机配备了 Sony® 的最新卷帘快门式 Starvis™ CMOS 传感器和全局快门式 Pregius™ CMOS 传感器，分辨率为 200-2000 万像素，可用于航空成像、智能交通系统 (ITS)、机器人检查解决方案和生命科学等领域的各种成像应用。Teledyne Lumenera 的 Lt 系列相机提供了体积更小、重量更轻、成本更低的成像解决方案，专为应对当今的现代成像系统挑战而设计，这些系统力求在提供更佳视觉性能的同时减少耗费功率和占用空间，适应日益紧张的行业预算。”Teledyne Lumenera 总经理 Ghislain Beaupré 说， “即使外形比以前更紧凑，新型 Lt 系列相机也能提供现代成像行业所需的全套功能。“这些新型相机为成像系统设计人员提供了新机会，使他们能够将全功能相机整合到一起，而不会因为尺寸大小而造成不必要的性能损失。”Teledyne Lumenera Lt 系列相机为 Windows、Linux、嵌入式系统平台的 Linux 和单板计算机 (SBC) 提供经验证的 32 位和 64 位操作系统兼容性。该系列相机经过精心设计，可为工业和科学成像应用提供高动态范围、高速和低读取噪声等性能。主要特点：13 款发布的新型 USB3 相机的分辨率范围为 200 万至 1200 万像素，随后将有更多的分辨率灵敏度高（像素尺寸范围 2 μm 至 3.45 μm），背照式传感器紧凑的外形，简化了与现代 OEM 解决方案的集成用于电源和控制的侧面安装的可锁定工业级微型...

カナダ、オタワ, June 02, 2020 (GLOBE NEWSWIRE) — Teledyne Technologies（NYSE: TDY）の傘下で、産業用・研究用イメージング用途のデジタルカメラ製造・開発会社であるTeledyne Lumeneraは、新しいLtシリーズUSB3カメラを発表しました。堅牢でコンパクトな筐体とUSB3完全ロックコネクターを備えたこれらの新しいカメラは、24時間365日の稼働に耐える頑丈な構造になっています。さらに、Sony®製の最新のローリングシャッターStarvis™ CMOSセンサーとグローバルシャッターPregius™ CMOSセンサーを搭載し、2～20メガピクセルの解像度モデルをラインナップしています。、航空撮影、高度道路交通システム（ITS）、ロボットによる検査ソリューション、ライフサイエンスなどの多種多様なイメージング用途に威力を発揮します。Teledyne Lumenera Ltシリーズカメラは、小型、軽量、低コストを特徴とするイメージングソリューションを提供します。このソリューションは、省電力、省スペース、そして日増しに厳しくなる産業分野の予算といった要件を満たしながら、最新のビジョン性能を提供するという、今日のイメージングシステムの課題を満たすよう特別に設計されています。「新しいLtシリーズカメラは、今日のイメージング業界が求める機能すべてを一段と小型の形状で提供します」と、Teledyne LumeneraのゼネラルマネージャーであるGhislain Beaupréは述べ、次のように続けました。「これらのカメラにより、イメージングシステム設計者は、性能面でサイズ的な制約による不必要な妥協をすることなく、包括的な機能を有するカメラを搭載する新しい機会を得られます。」Teledyne Lumenera Ltシリーズカメラでは、Windows、Linux、組み込みシステムプラットフォーム用Linux、そしてシングルボードコンピューター（SBC）などの、32ビットおよび64ビットオペレーティングシステムと互換性があります。カメラは、産業用および科学分野の両方におけるイメージング用途として、ハイダイナミックレンジ、ハイスピードを低読み出しノイズで実現するように設計されています。主な機能：新しいUSB3カメラは、解像度2～12...

Denver, CO, June 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Helix Technologies, Inc. (OTCQB: HLIX) (the “Company”) announced today the release of Cannalytics Business Intelligence for cultivators, a groundbreaking data platform that delivers deep insights into the production end of the cannabis industry.  The platform is the industry’s first BI tool that integrates into cultivation software allowing growers to track and forecast yields, predict harvests, track yields on a strain by strain basis and maximize working capital availability through inventory management.  “Helix has quietly been on the leading edge of innovation in cannabis, in the same focused way we’ve continued to grow our market share and deliver new technology,” said Garvis Toler, Helix Technologies’ President of Data Services.  “Not only are we bringing...

EXTON, Pa., June 02, 2020 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA; the “Company”) today announced preliminary data from the first 10 patients in the safety cohort of  ILLUMINATE-206, a Phase 2, open-label, multi-center study to evaluate tilsotolimod in combination with Opdivo® (nivolumab) and Yervoy®* (ipilimumab) in immunotherapy-naive micro-satellite stable colorectal cancer (MSS-CRC) patients. Based on data to date, the Company plans to expand the study to further evaluate this triplet combination in MSS-CRC.To investigate the safety profile of this triplet combination, ILLUMINATE-206 was designed with a stepwise approach to Yervoy® dosage. Patients in this initial safety cohort of the study, many of whom were heavily pre-treated and rapidly progressing, received 8 mg of intratumoral tilsotolimod and 3 mg/kg...

Atlanta, June 02, 2020 (GLOBE NEWSWIRE) — Acuity Brands, Inc. (NYSE: AYI) will host a conference call on Tuesday, June 30, 2020, at 10:00 a.m. (EDT) to discuss the Company’s performance for the third quarter of fiscal 2020, following the announcement of those results earlier that day.  Neil M. Ashe, President and Chief Executive Officer of Acuity Brands, will lead the call.  A live Webcast of the discussion will be accessible at the Company’s Website:  www.acuitybrands.com.  A replay of the call will also be posted to that site within two hours of the completion of the conference call and will be archived on the site. About Acuity Brands  Acuity Brands, Inc. (NYSE: AYI) is a market-leading industrial technology company. We design, manufacture, and bring to market innovative products and services that make the world more brilliant,...

RICHLAND, Wash., June 02, 2020 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE American: ISR) today announced that the results of a new ten year study show positive outcomes for low-risk and intermediate-risk prostate cancer patients treated with Isoray’s Cesium-131 (Cesium Blu) internal radiation therapy (brachytherapy).Dr. Ronald Benoit, lead author of the study from the Department of Urology, University of Pittsburgh School of Medicine, addressed the findings, “As our data matures, our findings continue to demonstrate the excellent oncologic outcomes in men undergoing prostate brachytherapy with Cesium-131.” Speaking to the data on higher risk cancers, Dr. Benoit noted, “We do believe our long-term outcomes in men with high risk disease are somewhat underestimated in this manuscript due to a low number of patients at risk at ten years....